Melanoma in children

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 3, 2011, Pages 307-316

  Paradela, Sabela ^a   Fonseca, Eduardo ^b   Prieto, Victor G ^c  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c University of Texas M D Anderson Cancer Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ARTICLE; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MELANOMA; METABOLISM; METASTASIS; MUCOSA; NEVUS; PATHOLOGY; PRESCHOOL CHILD; SKIN TUMOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MELANOMA; MUCOUS MEMBRANE; NEVUS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952924709     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (96)

1. Hamre MR, Chuba P, Bakhshi S, Thomas R, Severson RK. Cutaneous melanoma in childhood and adolescence. Pediatr Hematol Oncol. 2002; 19(5): 309-317. (Pubitemid 34633365)
2. de Vries E, Steliarova-Foucher E, Spatz A, et al. Skin cancer incidence and survival in European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42(13): 2170-2182.
3. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N Engl J Med. 1995; 332(10): 656-662.
4. World Health Organization, International Agency for Research on Cancer, International Association of Cancer Registries. Melanoma. In: Parkin DM, Kramárová E, Draper GJ, et al., eds. International Incidence of Childhood Cancer. Vol 2. Lyon, France: IARC Press; 1998: 43-444. IARC Scientific Publications; no. 144.
5. Ries LAG, Smith MA, Gurney JG, et al., eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. Bethesda, MD: National Institutes of Health; 1999. Publication no. 99-4649.
6. Prosdocimo T, Smith M, Polack EP. The diagnosis and treatment of childhood melanoma. W V Med J. 2002; 98(4): 149-151.
7. Saenz NC, Saenz-Badillos J, Busam K, LaQuaglia MP, Corbally M, Brady MS. Childhood melanoma survival. Cancer. 1999; 85(3): 750-754. (Pubitemid 29075297)
8. van Dijk MC, Aben KK, van Hees F, et al. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions. Histopathology. 2008; 52(2): 139-146.
9. Vandeweyer E, Sales F, Deraemaecker R. Cutaneous malignant melanoma in children. Eur J Pediatr. 2000; 159(8): 582-584. (Pubitemid 30469444)
10. Eedy DJ. Malignant melanoma in childhood. Br J Dermatol. 1997; 136(1): 137-138.
11. Paradela S, Fonseca E, Pita-Fernández S, et al. Prognostic factors in melanoma in children and adolescents: a clinicopathologic, single-centre study of 137 patients. Cancer. 2010. In press.
12. Lewis KG. Trends in pediatric melanoma mortality in the United States, 1968 through 2004. Dermatol Surg. 2008; 34(2): 152-159.
13. Conti EM, Cercato MC, Gatta G, Ramazzotti V, Roscioni S; EUROCARE Working Group. Childhood melanoma in Europe since 1978: a population-based survival study. Eur J Cancer. 2001; 37(6): 780-784. (Pubitemid 32304415)
14. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005, 23(21): 4735-4741. (Pubitemid 46224077)
15. Berg P, Lindelöf B. Differences in malignant melanoma between children and adolescents: a 35-year epidemiological study. Arch Dermatol. 1997; 133(3): 295-297. (Pubitemid 27142319)
16. Melnik MK, Urdaneta LF, Al-Jurf AS, Foucar E, Jochimsen PR, Soper RT. Malignant melanoma in childhood and adolescence. Am Surg. 1986; 52(3): 142-147. (Pubitemid 16160016)
17. Temple WJ, Mulloy RH, Alexander F, Marx LH, Jenkins M, Jerry LM. Childhood melanoma. J Pediatr Surg. 1991; 26(2): 135-137.
18. Richardson SK, Tannous ZS, Mihm MC Jr. Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigmentsynthesizing melanoma. J Am Acad Dermatol. 2002; 47(1): 77-90.
19. Tate PS, Ronan SG, Feucht KA, Eng AM, Das Gupta TK. Melanoma in childhood and adolescence: clinical and pathological features of 48 cases. J Pediatr Surg. 1993; 28(2): 217-222. (Pubitemid 23064349)
20. de Sá BC, Rezze GG, Scramim AP, Landman G, Neves RI. Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients. Melanoma Res. 2004; 14(6): 487-492. (Pubitemid 40221139)
21. Schmid-Wendtner MH, Berking C, Baumert J, et al. Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients. J Am Acad Dermatol. 2002; 46(6): 874-879.
22. Crotty KA, McCarthy SW, Palmer AA, et al. Malignant melanoma in childhood: a clinicopathologic study of 13 cases and comparison with Spitz nevi. World J Surg. 1992; 16(2): 179-185.
23. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults: a retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005; 115(3): 649-654. (Pubitemid 43373024)
24. Valcayo-Peñalba A, Sánchez-Yus E. El melanoma maligno en menores de quince años (MM sub-15): un problema poco y mal estudiado (in Spanish). Actas Dermosifiliogr. 1986; 77(12): 717-723.
25. Sander B, Karlsson P, Rosdahl I, Westermark P, Boeryd B. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinicopathological study of 130 cases. Int J Cancer. 1999; 80(5): 646-651. (Pubitemid 29066271)
26. Jafarian F, Powell J, Kokta V, et al. Malignant melanoma in childhood and adolescence: report of 13 cases. J Am Acad Dermatol. 2005; 53(5): 816-822. (Pubitemid 41501367)
27. Mones JM, Ackerman AB. Melanomas in prepubescent children: review comprehensively, critique historically, criteria diagnostically, and course biologically. Am J Dermatopathol. 2003; 25(3): 223-238. (Pubitemid 36706464)
28. Karlsson P, Boeryd B, Sander B, Westermark P, Rosdahl I. Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92. Acta Derm Venereol. 1998; 78(4): 289-292. (Pubitemid 28328924)
29. Karlsson PM, Fredrikson M. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken. Int J Cancer. 2007; 121(2): 323-328. (Pubitemid 46917701)
30. Ruiz-Maldonado R, Orozco-Covarrubias ML. Malignant melanoma in children: a review. Arch Dermatol. 1997; 133(3): 363-371.
31. Fishman C, Mihm MC Jr, Sober AJ. Diagnosis and management of nevi and cutaneous melanoma in infants and children. Clin Dermatol. 2002; 20(1): 44-50. (Pubitemid 34158710)
32. Lange JR, Balch CM. Melanoma in children: heightened awareness of an uncommon but often curable malignancy. Pediatrics. 2005; 115(3): 802-803. (Pubitemid 43373048)
33. Schaffer JV. Pigmented lesions in children: when to worry. Curr Opin Pediatr. 2007; 19(4): 430-440. (Pubitemid 47075625)
34. Pappo AS. Melanoma in children and adolescents. Eur J Cancer. 2003; 39(18): 2651-2661. (Pubitemid 37468306)
35. Whiteman DC, Valery P, McWhirter W, Green AC. Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer. 1997; 70(1): 26-31. (Pubitemid 27059701)
36. Hoang MT, Friedlander SF. Rare cutaneous malignancies of childhood. Curr Opin Pediatr. 1999;11(5): 464-470. (Pubitemid 29463069)
37. Spatz A, Ruiter D, Hardmeier T, et al. Melanoma in childhood: an EORTCMCG multicenter study on the clinico-pathological aspects. Int J Cancer. 1996; 68(3):317-324. (Pubitemid 26384134)
38. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987; 123(2): 241-250. (Pubitemid 17002499)
39. Berg P, Wennberg AM, Tuominen R, et al. Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma. Melanoma Res. 2004; 14(4): 251-255. (Pubitemid 39159136)
40. Leech SN, Bell H, Leonard N, et al. Neonatal giant congenital nevi with proliferative nodules: a clinicopathologic study and literature review of neonatal melanoma. Arch Dermatol. 2004; 140(1): 83-88. (Pubitemid 38090274)
41. Paradela S, Fernández-Torres R, Fonseca E. Controversial issues in congenital nevi [in Spanish]. Actas Dermosifiliogr. 2009; 100(7): 548-561.
42. Huynh PM, Grant-Kels JM, Grin CM. Childhood melanoma: update and treatment. Int J Dermatol. 2005; 44(9): 715-723. (Pubitemid 41301004)
43. Lefkowitz A, Schwartz RA, Janniger CK. Melanoma precursors in children. Cutis. 1999; 63(6): 321-324.
44. Barnhill, RL. Pathology of Melanocytic Nevi and Malignant Melanoma. 2nd ed. New York, NY: Springer; 2004.
45. Kefford RF, Newton Bishop JA, Bergman W, Tucker MA. Counselling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol. 1999; 17(10): 3245-3251. (Pubitemid 29470659)
46. Greene MH. The genetics of hereditary melanoma and nevi: 1998 update. Cancer. 1999; 86(suppl 11): 2464-2477. (Pubitemid 30007529)
47. Youl P, Aitken J, Hayward N, et al. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int J Cancer. 2002; 98(1): 92-98. (Pubitemid 34113424)
48. Oeffinger KC, Mertens AC, Sklar CA, et al. Cancer survivor study: chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; 355(15): 1572-1582. (Pubitemid 44547808)
49. McKenna DB, Doherty VR, McLaren KM, Hunter JA. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br J Dermatol. 2000; 143(1): 171-173. (Pubitemid 30485264)
50. Corpron CA, Black CT, Ross MI, et al. Melanoma as a second malignant neoplasm after childhood cancer. Am J Surg. 1996; 172(5): 459-462. (Pubitemid 26415751)
51. Sybert V. Six children with malignant melanoma. J Am Acad Dermatol. 1991; 24(4): 666-667.
52. Paradela S, Fonseca E, Pita S, Kantrow SM, Goncharuk VN, Prieto VG. Spitzoid melanoma in children: clinico-pathologic study and application of immunohistochemistry as an adjunct diagnostic tool. J Cutan Pathol. 2009; 36(7): 740-752.
53. Rao BN, Hayes FA, Pratt CB, et al. Malignant melanoma in children: its management and prognosis. J Pediatr Surg. 1990; 25(2): 198-203. (Pubitemid 20046188)
54. Lange JR, Palis BE, Chang DC, Soong SJ, Balch CM. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol. 2007; 25(11): 1363-1368. (Pubitemid 46706883)
55. Livestro DP, Kaine EM, Michaelson JS, et al. Melanoma in the young: differences and similarities with adult melanoma-a case-matched controlled analysis. Cancer. 2007; 110(3): 614-624. (Pubitemid 47106151)
56. Spatz A, Avril MF. Melanoma in childhood: review and perspectives. Pediatr Dev Pathol. 1998; 1(6): 463-474. (Pubitemid 128542163)
57. Gibbs P, Moore A, Robinson W, Walsh P, Golitz L, Gonzalez R. Pediatric melanoma: are recent advances in the management of adult melanoma relevant to the pediatric population. J Pediatr Hematol Oncol. 2000; 22(5): 428-432. (Pubitemid 33599750)
58. Moss AL, Briggs JC. Cutaneous malignant melanoma in the young. Br J Plast Surg. 1986; 39(4): 537-541. (Pubitemid 17205650)
59. Aldrink JH, Selim MA, Diesen DL, et al. Pediatric melanoma: a singleinstitution experience of 150 patients. J Pediatr Surg. 2009; 44(8): 1514-1521.
60. Davidoff AM, Cirrincione C, Seigier HF. Malignant melanoma in children. Ann Surg Oncol. 1994; 1(4): 278-282.
61. Barnhill RL Childhood melanoma. Semin Diagn Pathol. 1998; 15(3): 189-194.
62. Kaddu S, Smolle J, Zenahlik P, Hofmann-Wellenhof R, Kerl H. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis. Melanoma Res. 2002; 12(3): 271-278. (Pubitemid 34666818)
63. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999; 30(5): 513-520. (Pubitemid 29218042)
64. Spatz A, Calonje E, Handfield-Jones S, Barnhill RL. Spitz tumors in children: a grading system for risk stratification. Arch Dermatol. 1999; 135(3): 282-285. (Pubitemid 29159210)
65. Leech SN, Bell H, Leonard N, et al. Neonatal giant congenital nevi with proliferative nodules: a clinicopathologic study and literature review of neonatal melanoma. Arch Dermatol. 2004; 140(1): 83-88. (Pubitemid 38090274)
66. McKee PH, Calonje E. Diagnostic Atlas of Melanocytic Pathology. 1st ed. Philadelphia, PA: Mosby; 2009.
67. Herron MD, Vanderhooft SL, Smock K, Zhou H, Leachman SA, Coffin C. Proliferative nodules in congenital melanocytic nevi: a clinicopathologic and immunohistochemical analysis. Am J Surg Pathol. 2004; 28(8): 1017-1025. (Pubitemid 38971425)
68. Florell SR, Coffin CM. Diagnostically challenging melanocytic lesions in children. Pathol Case Rev. 2009; 14: 85-92.
69. McNutt NS. "Triggered trap": nevoid malignant melanoma. Semin Diagn Pathol. 1998; 15(3): 203-209. (Pubitemid 28369194)
70. Kamino H. Spitzoid melanoma. Clin Dermatol. 2009; 27(6): 545-555.
71. Barnhill RL, Gupta K. Unusual variants of malignant melanoma. Clin Dermatol. 2009; 27(6): 564-587.
72. Trozak DJ, Rowland WD, Hu F. Metastatic malignant melanoma in prepubertal children. Pediatrics. 1975; 55(2): 191-204.
73. Bergman R, Malkin L, Sabo E, Kerner H. MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi. J Am Acad Dermatol. 2001; 44(3): 500-504.
74. Lourenço SV, A MS, Sotto MN, et al. Primary oral mucosal melanoma: a series of 35 new cases from South America. Am J Dermatopathol. 2009; 31(4): 323-330.
75. Owens JM, Gomez JA, Byers RM. Malignant melanoma in the palate of a 3-month-old child. Head Neck. 2002; 24(1): 91-94. (Pubitemid 34013861)
76. Shah JP, Huvos AG, Strong EW. Mucosal melanomas of the head and neck. Am J Surg. 1977; 134(4): 531-535. (Pubitemid 8201801)
77. Harrison DF. Malignant melanomata arising in the nasal mucous membrane. J Laryngol Otol. 1976; 90(11): 993-1005.
78. Ravid JM, Esteves JA. Malignant melanoma of the nose and paranasal sinuses and juvenile melanoma of the nose. Arch Otolaryngol. 1960; 72: 431-444.
79. Hanchard B, Salmon B. Primary malignant melanoma of the maxillary gingiva in a 4-year-old girl. West Indian Med J. 1985; 34(4): 278-281. (Pubitemid 16193261)
80. McNutt NS, Urmacher C, Hakimian J, Hoss DM, Lugo J. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity. I Cutan Pathol. 1995; 22(6): 502-517. (Pubitemid 26013708)
81. Palazzo J, Duray PH. Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study. Hum Pathol. 1989; 20(4): 341-346. (Pubitemid 19102125)
82. Bergman R, Dromi R, Trau H, Cohen I, Lichtig C. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol. 1995; 17(6): 542-546. (Pubitemid 26010177)
83. Ruhoy SM, Prieto VG, Eliason SL, Grichnik JM, Burchette JL, Shea CR. Malignant melanoma with paradoxical maturation. Am J Surg Pathol. 2000; 24: 1600-1614.
84. Butter A, Hui T, Chapdelaine J, Beaunoyer M, Flageole H, Bouchard S. Melanoma in children and the use of sentinel lymph node biopsy. J Pediatr Surg. 2005; 40(5): 797-800. (Pubitemid 40724850)
85. Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol. 2002; 6(4): 257-264.
86. Toro J, Ranieri JM, Havlik RJ, et al. Sentinel lymph node biopsy in children and adolescents with malignant melanoma. J Pediatr Surg. 2003; 38(7): 1063-1065. (Pubitemid 36828876)
87. Dessureault S, Soong SJ, Ross MI, et al. American Joint Committee on Cancer (AJCC) Melanoma Staging Committee: improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol. 2001; 8(10): 766-770. (Pubitemid 34003324)
88. Roaten JB, Partrick DA, Bensard D, et al. Survival in sentinel lymph nodepositive pediatric melanoma. J Pediatr Surg. 2005; 40(6): 988-992. (Pubitemid 40846472)
89. Ra JH, McMasters KM, Spitz FR. Should all melanoma patients undergo sentinel lymph node biopsy? Curr Opin Oncol. 2006; 18(2): 185-188. (Pubitemid 43740440)
90. Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol. 2002, 26(1): 47-55. (Pubitemid 34019991)
91. Murali R, Sharma RN, Thompson JF, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol. 2008; 1501: 302-309.
92. Urso C, Borgognoni L, Saieva C, et al. Sentinel lymph node biopsy in patients with "atypical Spitz tumors": a report on 12 cases. Hum Pathol. 2006; 37(7): 816-823. (Pubitemid 43902939)
93. Gamblin TC, Edington H, Kirkwood JM, Rao UN. Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features. Ann Surg Oncol. 2006; 13(12): 1664-1670. (Pubitemid 44951475)
94. Naasan A, al-Nafussi A, Quaba A. Cutaneous malignant melanoma in children and adolescents in Scotland, 1979-1991. Plast Reconstr Surg. 1996; 98(3): 442-446. (Pubitemid 26268743)
95. Aldrink JH, Selim MA, Diesen DL, et al. Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg. 2009; 44(8): 1514-1521.
96. Howman-Giles R, Shaw HM, Scolyer RA, et al. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients. Ann Surg Oncol. 2010; 17(1): 138-143.